Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
News|Articles|August 2, 2003
- Pharmaceutical Technology-08-02-2003
- Volume 27
- Issue 8
BIO Update
Author(s)Jim Miller
The Biotechnology Industry Organization lends insight into the trends of biopharmaceutical contract manufacturing.
Advertisement
Articles in this issue
about 23 years ago
Designing Transfer Carts for Class 100 Conditionsabout 23 years ago
An Update on Osmotic Drug Deliveryabout 23 years ago
New FDA Initiatives Aim to Spur Innovationabout 23 years ago
Interphex Serves as a Showcase for New Materials and Machinesabout 23 years ago
August 2003about 23 years ago
In the Spotlight August 2003Advertisement
Related to this article
Shilpa Pharma Lifesciences Limited will launch a new small-molecule CDMO at CPHI Milan in October.
This article explains the 4 shifts enabling faster, lower-risk, commercially successful biologics technology transfer.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
3
PharmTech’s Weekly Roundup—September 25, 2026
4
PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP
5